News

You are here:

Home
News

Innovations in Biodiesel, Methanol Production, and Wastewater Treatment – ResearchAndMarkets.com

May 18, 2020

DUBLIN–(BUSINESS WIRE)–The “Innovations in Biodiesel, Methanol Production, and Wastewater Treatment” report has been added to ResearchAndMarkets.com’s offering. This edition of the Industrial Bioprocessing Technology Opportunity Engine (TOE) features trends and innovations based on the utilization of sewage sludge for the manufacture of bio-diesel and the use of photo-catalytic method to produce methanol and syngas. The…

Details

Halo to Postpone Reporting Interim Financial Results Due to Delays Caused by the COVID-19 Pandemic

May 15, 2020

TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company“) (NEO:HALO, OTCQX:AGEEF, Germany:A9KN) today announces that, due to delays caused by the COVID-19 pandemic, it is relying on the exemption provided in Ontario Instrument 51-502 – Temporary Exemption from Certain Corporate Finance Requirements (the “Instrument“) of the Ontario Securities Commission (and similar exemptions provided by other Canadian…

Details

Drug Delivery Partnering Deals Collection 2014-2020 – ResearchAndMarkets.com

May 15, 2020

DUBLIN–(BUSINESS WIRE)–The “Global Drug Delivery Partnering Terms and Agreements 2014-2020” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides details of the latest Drug Delivery agreements announced in the life…

Details

Transdermal Drug Delivery Industry Assessment 2018-2028 Featuring Profiles of 100 Companies along with 105 Collaborations – ResearchAndMarkets.com

May 15, 2020

DUBLIN–(BUSINESS WIRE)–The “Transdermal Drug Delivery – Technologies, Markets, and Companies” report from Jain PharmaBiotech has been added to ResearchAndMarkets.com’s offering. This report deals with transdermal drug delivery – an approach used to deliver drugs through the skin for therapeutic use as an alternative to oral, intravascular, subcutaneous and transmucosal routes. Various transdermal drug delivery technologies…

Details

Tenet to Participate in the UBS Global Healthcare Conference

May 15, 2020

DALLAS–(BUSINESS WIRE)–Tenet Healthcare Corporation (NYSE: THC) will participate in the UBS Global Healthcare Conference on Tuesday, May 19. This conference has shifted to a virtual format for 2020. Tenet’s presentation is scheduled to begin at approximately 9:10 a.m. Eastern time (8:10 a.m. Central time). A live webcast and audio archive of the event may be…

Details

Global Medical Cannabis Market Insights 2020, Featuring Insys Therapeutics, Alkem Laboratories, Akorn and Ascent Pharmaceuticals – ResearchAndMarkets.com

May 15, 2020

DUBLIN–(BUSINESS WIRE)–The “Medical Cannabis Market Insights 2020, Analysis and Forecast Global and Chinese Market to 2025, by Manufacturers, Regions, Technology, Product Type” report has been added to ResearchAndMarkets.com’s offering. The “2020 Global and Chinese Medical Cannabis” report provides key statistics on the market for medical cannabis. It is a valuable source of guidance and direction…

Details

Mentor Capital Reports 1st Quarter 2020 10-Q

May 15, 2020

SAN DIEGO–(BUSINESS WIRE)–Mentor Capital, Inc. (OTCQB: MNTR) announced that it had filed its quarterly Form 10-Q filing for the first quarter ended March 31, 2020, with the Securities and Exchange Commission coincident with a move to the OTCQB. The Company reports that for the quarter ended March 31, 2020, Mentor had revenues of $1,149,462 and…

Details

Sproutly Announces a Business Transformation Plan and Investment by Infusion Biosciences

May 14, 2020

VANCOUVER, British Columbia–(BUSINESS WIRE)–Sproutly Canada, Inc. (CSE:SPR) (OTCQB:SRUTF) (FSE:38G) (“Sproutly” or the “Company”) announces a business transformation plan that will shift the Company’s resources away from cannabis cultivation to focus on the commercialization of its proprietary APP Technology (the “Business Transformation Plan”). As part of the implementation of the Business Transformation Plan, Infusion Biosciences Inc.…

Details

FSD Pharma Reports First Quarter 2020 Financial Results

May 14, 2020

TORONTO–(BUSINESS WIRE)–FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today reported that management’s discussion and analysis of financial condition and results of operations (“MD&A”) for the three months ended March 31, 2020 have been filed and can be viewed on the Company’s SEDAR profile at www.sedar.com. FSD also provided…

Details

Cresco Labs to Report First Quarter 2020 Financial Results on May 28, 2020

May 14, 2020

CHICAGO–(BUSINESS WIRE)–Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report its financial results for the first quarter ended March 31, 2020 on Thursday, May 28th, 2020 after market close. The Company will host a conference call and…

Details

Shareholder Alert: Robbins LLP Announces iAnthus Capital Holdings, Inc. (ITHUF) Sued for Misleading Shareholders

May 14, 2020

SAN DIEGO & NEW YORK–(BUSINESS WIRE)–Shareholder rights law firm Robbins LLP announces that a purchaser of iAnthus Capital Holdings, Inc. (OTC: ITHUF) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between May 14, 2018 and April 6, 2020. iAnthus owns and operates licensed cannabis cultivation,…

Details

Applied DNA Reports 2020 Fiscal Second Quarter Financial Results

May 14, 2020

STONY BROOK, N.Y.–(BUSINESS WIRE)–Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting and anti-theft technology, today announced consolidated financial results for the fiscal second quarter and the six months…

Details